1. Medtech Insight
  2. >>Device Area
  3. >>Orthopedics

AAOS 2024: Stryker’s Lisa Kloes On Triathlon Hinge Implant, myMako For Mixed Reality Surgery Support

 
• By Marion Webb

Stryker is showcasing its latest innovation in knee revision surgery, the Triathlon Hinge implant, and preparing to introduce a new myMako app to surgeons for anytime visualization and review of patients’ Mako surgical plans using Apple Vision Pro or iPhone.

Knee surgery
• Source: Alamy

With the biggest annual orthopedics gathering underway in San Francisco, Stryker Corporation is showcasing its latest innovation in knee revision surgery, the Triathlon Hinge implant, and introducing a new addition to its robotic surgical platform Mako, myMako app, for the Apple Vision Pro headset and iPhone.

Stryker’s Triathlon Hinge knee system is the newest addition to Stryker’s Triathlon Knee System, which is celebrating its 20th anniversary....

Welcome to Medtech Insight

Create an account to read this article

Already a subscriber?

More from Orthopedics

More from Device Area

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 
• By Natasha Barrow

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

Endo Tools, Fujifilm Partner to Fast-Track Endomina Rollout Across MEA Region

 
• By Shubham Singh

CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.

From Imitation To Action: Johns Hopkins Robot Autonomously Performs Key Step In Gallbladder Surgery

 
• By Marion Webb

Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.